Access to the full 21st Annual International Symposium on Inborn Errors of Immunity (October 2–4, 2026, at VEA Newport Beach, California). Includes attendance at all scientific sessions, keynote lectures (including the William E. Paul Award and Thomas A. Waldmann Award presentations), expert panel discussions, and networking opportunities with leading global immunologists. Ideal for clinicians, researchers, and healthcare professionals interested in the latest advances in phenotype expansion, gene therapy, immunometabolism, and related topics.

Premium access for industry professionals and corporate representatives. Includes all General Admission benefits plus enhanced visibility and networking opportunities at this premier gathering of immunology experts. Supports the Foundation for Primary Immunodeficiency Diseases (FPID) mission while providing a dedicated platform to engage with decision-makers in research, therapeutics, and clinical care. Perfect for sponsors, exhibitors, or organizations advancing treatments for inborn errors of immunity.

Discounted full-access registration for current students in relevant fields (medicine, immunology, biology, etc.). Includes attendance at all symposium sessions, award lectures, and networking events. A valuable opportunity to learn directly from world-renowned experts on cutting-edge topics like gene editing, thymus transplantation, non-coding variants, and novel therapeutics. Proof of student status may be required.

Special rate for clinical or research fellows/trainees. Provides full access to the three-day program, including scientific presentations, abstract sessions, and interactions with leaders in the field. Designed to support the next generation of immunologists advancing understanding and treatment of inborn errors of immunity. Verification of fellowship status may be required.